Evidence map›Paper›PMID 41062856›Full record

ArticleCalcified tissue international2025

Severe Osteoporosis in Larsen Syndrome-A Case Report of Bone Morphology and A Novel Filamin B (FLNB) Variant.

Trine Maxel Juul, Lisbeth Koch Thomsen, Christina Møller Andreasen, Charlotte Ejersted, Lars Folkestad, Klaus Brusgaard, Stinus Hansen, Jesper Skovhus Thomsen, Thomas Levin Andersen, Anja Lisbeth Frederiksen

Abstract readCase Reports
In one paragraph

Article in Calcified tissue international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Trine Maxel JuulDepartment of Clinical Genetics, Odense University Hospital (OUH), Odense, Denmark. Trine.Maxel.Juul@rsyd.dk.ORCID http://orcid.org/0000-0001-9421-3004
Lisbeth Koch ThomsenMolecular Bone Histology Lab, Pathology Research Unit, Department of Clinical Research, University of Southern Denmark (SDU), Odense, Denmark.ORCID http://orcid.org/0000-0002-7552-5974
Christina Møller AndreasenMolecular Bone Histology Lab, Pathology Research Unit, Department of Clinical Research, University of Southern Denmark (SDU), Odense, Denmark.ORCID http://orcid.org/0000-0002-2624-5677
Charlotte EjerstedDepartment of Endocrinology M, OUH, Odense, Denmark.
Lars FolkestadDepartment of Endocrinology M, OUH, Odense, Denmark.ORCID http://orcid.org/0000-0001-6266-6439
Klaus BrusgaardDepartment of Clinical Genetics, Odense University Hospital (OUH), Odense, Denmark.
Stinus HansenDepartment of Regional Health Research, SDU, Odense, Denmark.ORCID http://orcid.org/0000-0001-9486-0316
Jesper Skovhus ThomsenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-9386-6679
Thomas Levin AndersenMolecular Bone Histology Lab, Pathology Research Unit, Department of Clinical Research, University of Southern Denmark (SDU), Odense, Denmark.ORCID http://orcid.org/0000-0002-6981-7276
Anja Lisbeth FrederiksenDepartment of Clinical Genetics, Odense University Hospital (OUH), Odense, Denmark.ORCID http://orcid.org/0000-0002-7944-8910

Funding

Region Syddanmark 20/14779
6 · The paper itself

Abstract

Larsen syndrome is a rare genetic condition characterized by facial dysmorphism and skeletal deformities. It is caused by heterozygous pathogenic variants in the Filamin B encoding gene (FLNB). FLNB is a cytoskeletal protein that plays a key role in bone morphogenesis; however, the skeletal phenotype of Larsen syndrome has not been described in detail. Here, we studied the skeletal presentation in two subjects with Larsen syndrome. A case-study including a 63-year-old women and her 33-year-old daughter with Larsen syndrome, both carrying a novel FLNB c.688G > T, p.(Val230Phe) variant. The bone morphologic evaluation included, radiographs, bone mineral density assessment, and high-resolution peripheral quantitative tomography (HR-pQCT). In addition, a transiliac crest bone biopsy from the mother was evaluated by µCT, histomorphometry, and in situ examination of FLNB expression within physiological human bone remodeling sites of controls. Both women were diagnosed with severe osteoporosis (T-score < -5). The HR-pQCT analysis showed a low trabecular bone volume, as well as a low cortical thickness compared to a healthy cohort. Histomorphometry and µCT analysis of the iliac bone biopsy confirmed low cortical thickness, and revealed a high density of small eroded and quiescent intracortical pores. The trabecular bone remodeling was not affected, while cortical remodeling events accumulated as small eroded pores and quiescent pores with an improved infilling. The FLNB variant is associated with low bone mineral density reflecting severe osteoporosis and an altered trabecular and cortical bone structure, while bone turnover was less affected at the time of analysis.

Indexed as

Bone and BonesFilaminsOsteochondrodysplasiasOsteoporosisAdultBone DensityFemaleHumansMiddle AgedMutationFilaminsFLNB protein, humanFilamin BFLNBLarsen SyndromeOsteoporosis

Identifiers

PMID41062856
PMCPMC12507938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.